======= DUSP3 ======= == Gene Information == * **Official Symbol**: DUSP3 * **Official Name**: dual specificity phosphatase 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1845|1845]] * **UniProt**: [[https://www.uniprot.org/uniprot/P51452|P51452]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DUSP3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DUSP3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600183|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Shows activity both for tyrosine-protein phosphate and serine-protein phosphate, but displays a strong preference toward phosphotyrosines. Specifically dephosphorylates and inactivates ERK1 and ERK2. {ECO:0000269|PubMed:10224087, ECO:0000269|PubMed:11863439}. |DSPc| |positive regulation of focal adhesion disassembly| |regulation of focal adhesion disassembly| |MAP kinase phosphatase activity| |peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity| |negative regulation of T cell receptor signaling pathway| |protein tyrosine kinase binding| |negative regulation of antigen receptor-mediated signaling pathway| |inactivation of MAPK activity| |positive regulation of adherens junction organization| |negative regulation of JNK cascade| |immunological synapse| |regulation of T cell receptor signaling pathway| |protein tyrosine/serine/threonine phosphatase activity| |cellular response to epidermal growth factor stimulus| |negative regulation of stress-activated MAPK cascade| |negative regulation of stress-activated protein kinase signaling cascade| |negative regulation of epidermal growth factor receptor signaling pathway| |phosphatase activity| |response to epidermal growth factor| |negative regulation of ERBB signaling pathway| |receptor tyrosine kinase binding| |negative regulation of chemotaxis| |regulation of cell-substrate junction assembly| |regulation of focal adhesion assembly| |regulation of antigen receptor-mediated signaling pathway| |negative regulation of ERK1 and ERK2 cascade| |regulation of adherens junction organization| |negative regulation of MAP kinase activity| |cytoskeletal protein binding| |regulation of epidermal growth factor receptor signaling pathway| |regulation of cell junction assembly| |regulation of ERBB signaling pathway| |protein tyrosine phosphatase activity| |peptidyl-tyrosine dephosphorylation| |negative regulation of T cell activation| |regulation of cell-matrix adhesion| |negative regulation of leukocyte cell-cell adhesion| |negative regulation of protein serine/threonine kinase activity| |negative regulation of lymphocyte activation| |positive regulation of mitotic cell cycle| |negative regulation of MAPK cascade| |negative regulation of cell-cell adhesion| |negative regulation of leukocyte activation| |regulation of JNK cascade| |negative regulation of cell activation| |regulation of cell-substrate adhesion| |regulation of chemotaxis| |protein dephosphorylation| |negative regulation of protein kinase activity| |regulation of stress-activated MAPK cascade| |regulation of stress-activated protein kinase signaling cascade| |negative regulation of kinase activity| |negative regulation of cell migration| |negative regulation of cell adhesion| |negative regulation of cell motility| |negative regulation of transferase activity| |regulation of ERK1 and ERK2 cascade| |regulation of leukocyte cell-cell adhesion| |dephosphorylation| |negative regulation of cellular component movement| |regulation of T cell activation| |negative regulation of locomotion| |regulation of MAP kinase activity| |negative regulation of response to external stimulus| |positive regulation of cell cycle| |regulation of cell-cell adhesion| |negative regulation of protein phosphorylation| |negative regulation of immune system process| |negative regulation of phosphorylation| |protein kinase binding| |cellular response to growth factor stimulus| |negative regulation of intracellular signal transduction| |regulation of lymphocyte activation| |regulation of protein serine/threonine kinase activity| |response to growth factor| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of protein modification process| |regulation of leukocyte activation| |regulation of mitotic cell cycle| |regulation of cell activation| |regulation of cell adhesion| |regulation of cellular response to stress| |regulation of MAPK cascade| |negative regulation of catalytic activity| |regulation of protein kinase activity| |regulation of cell migration| |regulation of kinase activity| |regulation of cell motility| |regulation of cellular component biogenesis| |regulation of transferase activity| |regulation of locomotion| |regulation of cellular component movement| |negative regulation of cellular protein metabolic process| |regulation of response to external stimulus| |negative regulation of protein metabolic process| |negative regulation of molecular function| |regulation of immune response| |regulation of cell cycle| |positive regulation of cellular component organization| |cellular response to endogenous stimulus| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |regulation of protein phosphorylation| |response to endogenous stimulus| |regulation of response to stress| |regulation of phosphorylation| |negative regulation of response to stimulus| |regulation of immune system process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of intracellular signal transduction| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp211|AICAR 240μM R05 exp211]]|1.7| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7813 * **Expression level (log2 read counts)**: 5.02 {{:chemogenomics:nalm6 dist.png?nolink |}}